/biz/ - Business & Finance

>>26305066

CGIX

Currently trading at $5 up 75% in after-hours trading on strong rumors of buyout by Gilead Sciences at $80 per share to be announced any day now and possibly tomorrow.

CLSN

Currently trading at $1.25 up 40% in after hours on rumored imminent Phase III Clinical Trial approval announcement, possibly tomorrow.

ACST

Acasti Pharma found using ticker (ACST) now have 2 analysts in total covering the stock. The consensus rating is ‘Buy’. The range between the high target price and low target price is between 3.15 and 1.89 with the average target price sitting at 2.52. With the stocks previous close at 0.63 this is indicating there is a potential upside of 300.0%.

https://firstresearchreports.com/acasti-pharma-acst-509-upside-analysts-predict-the-price-to-be-around-3-35-and-highly-bullish/

https://www.directorstalkinterviews.com/acasti-pharma---consensus-indicates-potential-300.0-upside/412954122

ONTX

Up from 0.35 to 0.75 per share in 30 days on sufficient funding into 2022, pending announcements of positive results from pending drugs coming as soon as days or weeks. Look for a huge permanent spike tomorrrow. This will climb well over $10 a share in 4 days to 4 months.

PPT Presentation: https://investor.onconova.com/static-files/5fe03f21-cc14-4820-a7a3-20e888a62b2c